← All indications
Gallbladder Neoplasms
Tumors or cancer of the gallbladder.
Drugs by status
Phase 4 trials (2)
Phase 3 trials (22)
Phase 2 trials (71)
- afatinib
- anlotinib
- autologous tumor infiltrating lymphocytes
- avelumab
- sorafenib
- becatecarin
- binimetinib
- irinotecan
- cobimetinib
- devimistat
- dolastatin
- doxorubicin
- cannabidiol
- gm-ct-01
- trametinib
- lapatinib
- aldesleukin
- palonosetron
- incomplete freund's adjuvant
- ramucirumab
- nivolumab
- mitomycin
- ixabepilone
- pembrolizumab
- lenvatinib
- vibostolimab
- seribantumab
- msk-2206
- pazopanib
- pemetrexed
- +41 more
Phase 1 trials (25)
- 7-hydroxystaurosporine
- Fosgemcitabine
- andes-1537
- mkc1106
- dkn-01
- guadecitabine
- her2bi-armed activated t cells
- motexafin gadolinium
- pegph20
- prostate specific membrane antigen
- ephb4-hsa fusion protein
- fowlpox-sargramostim
- recombinant fowlpox-cea(6d)/tricom vaccine
- interleukin-12
- dasatinib
- tricom-cea(6d)
- tucatinib
- veliparib
- cea-loaded dendritic cells
- adh-1
- sodium thiosulfate
- vmd-928
- eli-002
- sgn-b7h4v
- st-1898
Organizations
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 3 Indications (46)
- Merck Serono
- Eli Lilly
- Merck KGaA
- German Research Foundation
- The Christie NHS Foundation Trust
- National Cancer Institute (NCI)
- Canadian Cancer Trials Group
- Cancer Research Campaign
- Cancer Research UK
- Center Eugene Marquis
- Centre Georges Francois Leclerc
- University of London
- Harvard University
- Eastern Hepatobiliary Surgery Hospital
- ECOG-ACRIN Cancer Research Group
- Emory University
- Federation Francophone de Cancerologie Digestive
- Harbin Medical University
- Deutsche Krebshilfe e.V.
- Jilin University
- Kunming Medical University
- LanZhou University
- Qinghai University
- Shandong Provincial Hospital
- Southwest Oncology Group
- Shengjing Hospital
- Tata Memorial Hospital
- University of Hamburg
- UNICANCER
- University of Toronto
- +16 more
Organization Involved with Phase 2 Indications (53)
- Daiichi Sankyo
- Celgene
- Amgen
- Roche
- AstraZeneca
- Genentech
- Genzyme
- Sanofi
- Sanofi-Synthelabo
- AIO-Studien-gGmbH
- Bayer
- Chugai
- Galectin Therapeutics Inc.
- GlaxoSmithKline
- Simcere Pharmaceutical Co., Ltd
- Aarhus University
- Brown University
- Case Western Reserve University
- Cornell University
- Temple University
- Gottfried Wilhelm Leibniz Universität Hannover
- Hellenic Cooperative Oncology Group
- New Mexico Cancer Care Alliance
- Ohio State University
- Rutgers University
- Stanford University
- Swiss Group for Clinical Cancer Research
- University of Miami
- University of New Mexico
- University of Rochester
- +23 more
Organization Involved with Phase 1 Indications (15)
- Fennec Pharma
- Andes Biotechnologies
- National Institutes of Health (NIH)
- University of Pittsburgh
- Duke University
- Nanjing Medical University
- University of Nebraska
- University of Virginia
- Vanderbilt University
- City of Hope National Medical Center
- University of North Carolina at Chapel Hill
- MannKind Corp
- Vasgene Therapeutics, Inc
- Abingen Ltd
- Van Andel Research Institute
Organization Involved with Other Experimental Indications (3)